A novel calcineurin inhibitor– and sirolimus-free anti-LFA-1-based therapy enhances allogeneic islet survival and function in nonhuman primates
Publication
, Conference
Badell, IR; Turner, AP; Cano, JA; Avila, JG; Johnson, BE; Leopardi, FV; Swygert, SG; Strobert, EA; Kirk, AD; Larsen, CP
Published in: Journal of the American College of Surgeons
September 2009
Duke Scholars
Published In
Journal of the American College of Surgeons
DOI
ISSN
1072-7515
Publication Date
September 2009
Volume
209
Issue
3
Start / End Page
S56 / S56
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related Subject Headings
- Surgery
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Badell, I. R., Turner, A. P., Cano, J. A., Avila, J. G., Johnson, B. E., Leopardi, F. V., … Larsen, C. P. (2009). A novel calcineurin inhibitor– and sirolimus-free anti-LFA-1-based therapy enhances allogeneic islet survival and function in nonhuman primates. In Journal of the American College of Surgeons (Vol. 209, pp. S56–S56). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1016/j.jamcollsurg.2009.06.133
Badell, Idelberto R., Alexandra P. Turner, Jose A. Cano, Jose G. Avila, Brandi E. Johnson, Frank V. Leopardi, Sarah G. Swygert, Elizabeth A. Strobert, Allan D. Kirk, and Christian P. Larsen. “A novel calcineurin inhibitor– and sirolimus-free anti-LFA-1-based therapy enhances allogeneic islet survival and function in nonhuman primates.” In Journal of the American College of Surgeons, 209:S56–S56. Ovid Technologies (Wolters Kluwer Health), 2009. https://doi.org/10.1016/j.jamcollsurg.2009.06.133.
Badell IR, Turner AP, Cano JA, Avila JG, Johnson BE, Leopardi FV, et al. A novel calcineurin inhibitor– and sirolimus-free anti-LFA-1-based therapy enhances allogeneic islet survival and function in nonhuman primates. In: Journal of the American College of Surgeons. Ovid Technologies (Wolters Kluwer Health); 2009. p. S56–S56.
Badell, Idelberto R., et al. “A novel calcineurin inhibitor– and sirolimus-free anti-LFA-1-based therapy enhances allogeneic islet survival and function in nonhuman primates.” Journal of the American College of Surgeons, vol. 209, no. 3, Ovid Technologies (Wolters Kluwer Health), 2009, pp. S56–S56. Crossref, doi:10.1016/j.jamcollsurg.2009.06.133.
Badell IR, Turner AP, Cano JA, Avila JG, Johnson BE, Leopardi FV, Swygert SG, Strobert EA, Kirk AD, Larsen CP. A novel calcineurin inhibitor– and sirolimus-free anti-LFA-1-based therapy enhances allogeneic islet survival and function in nonhuman primates. Journal of the American College of Surgeons. Ovid Technologies (Wolters Kluwer Health); 2009. p. S56–S56.
Published In
Journal of the American College of Surgeons
DOI
ISSN
1072-7515
Publication Date
September 2009
Volume
209
Issue
3
Start / End Page
S56 / S56
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related Subject Headings
- Surgery
- 3202 Clinical sciences
- 1103 Clinical Sciences